Biotech China 2014

Oncology: Eli Lilly

Total Score People Score Events Score
20 18 15
Date Event Presentation Speakers
October 25, 2010 4th European Cardiac Safety Conference How can Assay Sensitivity be Demonstrated in Early Clinical Studies? Charles Benson
October 20, 2010 6th Annual Meeting of the Oligonucleotide Therapeutics Society Reduction in Survivin Levels in Cancer Patients with LY2181308 Michael Lahn
October 13, 2009 Accelerating Proof of Concept Eli Lilly’s Chorus Program: The Continuing Evolution of Accelerated Drug Development Terri A. Roberson
September 23, 2009 TRACK 1: Optimizing Clinical Trials : Third Annual Adaptive Clinical Trial Designs Design and Implementation of a Comprehensive Data Flow for a Seamless Adaptive Phase 2/3 Trial Marcia Brackman
August 5, 2009 New Frontiers in Cancer Drug Development Functional Definition of a Companion Diagnostic: Strategies for Fit-for-Purpose Development John C Bloom
June 9, 2009 Third Annual Cardiotoxicity and Drug Safety Post-Hoc Comparison of Alternative Analytical Methods in the Non-Inferiority Comparison of Drug to Placebo in a thorough QT Study Charles M. Beasley
April 7, 2009 Kinase Inhibitor Chemistry - Charting the Chemical Space Exploiting Kinase Polypharmacology in Cell Cycle Regulation via High-Content Imaging Jeffrey Sutherland
January 26, 2009 Biomarker Assay Development Utilizing a LC/MS/MS (MRM) Quantitative Targeted Biomarker Panel to Elucidate Multiple Biological Changes Simultaneously Jon Butler
January 26, 2009 7th Annual Partnering with Central Labs Chairperson’s Welcome Cynthia Lindemann
Risk Assessment : Current and Future Metrics Champion Consortium Metrics Initiatives David Rauh
Track B : Chairperson’s Opening Remarks David Rauh
Track B : Metrics Champion Consortium Imaging Performance Metrics Announcement David Rauh
Track C : Using the MCC ECG Metrics Steve Asbury
Chairperson’s Welcome Cynthia Lindemann
Track A : Overview of Metrics: Definition Refinement & Update from the Central Lab MCC Initiative Cynthia Lindemann
Track B : Chairperson’s Opening Remarks David Rauh
January 5, 2009 High Content Analysis Phenotypic Screening: A Complementary Drug Discovery Paradigm Jonathan A Lee
Application of High-Content Fingerprinting to Oncology Drug Discovery: Focus on in vitro and in vivo Phenocopying and Cancer Stem Cell Analysis Louis Stancato
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Panel Discussion: Obstacles to Development--Ten Barriers to Proving Agents are Effective and Safe Richard B GAYNOR
March 25, 2008 Molecular Diagnostics Chairperson’s Remarks Brian T Edmonds
March 25, 2008 CANCER MOLECULAR MARKERS Chairperson’s Remarks Brian T Edmonds
November 5, 2007 Second Annual Biomarkers Europe Nov (05-06) BIOMARKERS FOR EARLY CLINICAL TRIALS: Biomarkers in Early Oncology Clinical Trials (08:05-08:35) Michael Lahn
BIOMARKERS FOR EARLY CLINICAL TRIALS (08:00-12:15) Michael Lahn
BIOMARKER QUALIFICATION AND VALIDATION (15:45-17:45) Charles Benson
BIOMARKER QUALIFICATION AND VALIDATION: Biomarker Validation: Why, Which, and How? (15:45-16:15) Charles Benson
October 22, 2007 THE INDIA LIFE SCIENCES Forum Discovery & Definition Darren Carroll
Big Pharma Keynote Tom Bumol
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.